Selected research
Market Structure
Global Lesinurad Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lesinurad market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lesinurad include Ausun Pharmaceutical, Cayman Chemical, CHEMO, Clearsynth, Manus Aktteva Biopharma LLP, MSN Labs, Nifty Labs, Target Mol and UQUIFA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Lesinurad output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Lesinurad by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Lesinurad market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lesinurad and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lesinurad sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lesinurad market size, projected growth trends, production technologies, key applications, and end-use industries.
Lesinurad Segment by Company
Ausun Pharmaceutical
Cayman Chemical
CHEMO
Clearsynth
Manus Aktteva Biopharma LLP
MSN Labs
Nifty Labs
Target Mol
UQUIFA
Meso Chem
Vcare Pharmatech
Lesinurad Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Lesinurad Segment by Application
Research Institute
Pharmaceutical
Others
Lesinurad Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lesinurad market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lesinurad and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lesinurad.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Lesinurad market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lesinurad industry.
Chapter 3: Detailed analysis of Lesinurad market competition landscape. Including Lesinurad manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Lesinurad by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Lesinurad in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥ 98 %
- Purity ≥ 99 %
Applications
- Research Institute
- Pharmaceutical
- Others
Companies covered
- Ausun Pharmaceutical
- Cayman Chemical
- CHEMO
- Clearsynth
- Manus Aktteva Biopharma LLP
- MSN Labs
- Nifty Labs
- Target Mol
- UQUIFA
- Meso Chem
- Vcare Pharmatech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Lesinurad Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Lesinurad Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Lesinurad Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Lesinurad Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Lesinurad Market Dynamics
- 2.1 Lesinurad Industry Trends
- 2.2 Lesinurad Industry Drivers
- 2.3 Lesinurad Industry Opportunities and Challenges
- 2.4 Lesinurad Industry Restraints
3 Lesinurad Market by Manufacturers
- 3.1 Global Lesinurad Production Value by Manufacturers (2021-2026)
- 3.2 Global Lesinurad Production by Manufacturers (2021-2026)
- 3.3 Global Lesinurad Average Price by Manufacturers (2021-2026)
- 3.4 Global Lesinurad Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lesinurad Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Lesinurad Manufacturers, Product Type & Application
- 3.7 Global Lesinurad Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lesinurad Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lesinurad Players Market Share by Production Value in 2025
- 3.8.3 2025 Lesinurad Tier 1, Tier 2, and Tier 3
4 Lesinurad Market by Type
- 4.1 Lesinurad Type Introduction
- 4.1.1 Purity ≥ 98 %
- 4.1.2 Purity ≥ 99 %
- 4.2 Global Lesinurad Production by Type
- 4.2.1 Global Lesinurad Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Lesinurad Production by Type (2021-2032)
- 4.2.3 Global Lesinurad Production Market Share by Type (2021-2032)
- 4.3 Global Lesinurad Production Value by Type
- 4.3.1 Global Lesinurad Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Lesinurad Production Value by Type (2021-2032)
- 4.3.3 Global Lesinurad Production Value Market Share by Type (2021-2032)
5 Lesinurad Market by Application
- 5.1 Lesinurad Application Introduction
- 5.1.1 Research Institute
- 5.1.2 Pharmaceutical
- 5.1.3 Others
- 5.2 Global Lesinurad Production by Application
- 5.2.1 Global Lesinurad Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Lesinurad Production by Application (2021-2032)
- 5.2.3 Global Lesinurad Production Market Share by Application (2021-2032)
- 5.3 Global Lesinurad Production Value by Application
- 5.3.1 Global Lesinurad Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Lesinurad Production Value by Application (2021-2032)
- 5.3.3 Global Lesinurad Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Ausun Pharmaceutical
- 6.1.1 Ausun Pharmaceutical Company Information
- 6.1.2 Ausun Pharmaceutical Business Overview
- 6.1.3 Ausun Pharmaceutical Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.1.4 Ausun Pharmaceutical Lesinurad Product Portfolio
- 6.1.5 Ausun Pharmaceutical Recent Developments
- 6.2 Cayman Chemical
- 6.2.1 Cayman Chemical Company Information
- 6.2.2 Cayman Chemical Business Overview
- 6.2.3 Cayman Chemical Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.2.4 Cayman Chemical Lesinurad Product Portfolio
- 6.2.5 Cayman Chemical Recent Developments
- 6.3 CHEMO
- 6.3.1 CHEMO Company Information
- 6.3.2 CHEMO Business Overview
- 6.3.3 CHEMO Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.3.4 CHEMO Lesinurad Product Portfolio
- 6.3.5 CHEMO Recent Developments
- 6.4 Clearsynth
- 6.4.1 Clearsynth Company Information
- 6.4.2 Clearsynth Business Overview
- 6.4.3 Clearsynth Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.4.4 Clearsynth Lesinurad Product Portfolio
- 6.4.5 Clearsynth Recent Developments
- 6.5 Manus Aktteva Biopharma LLP
- 6.5.1 Manus Aktteva Biopharma LLP Company Information
- 6.5.2 Manus Aktteva Biopharma LLP Business Overview
- 6.5.3 Manus Aktteva Biopharma LLP Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.5.4 Manus Aktteva Biopharma LLP Lesinurad Product Portfolio
- 6.5.5 Manus Aktteva Biopharma LLP Recent Developments
- 6.6 MSN Labs
- 6.6.1 MSN Labs Company Information
- 6.6.2 MSN Labs Business Overview
- 6.6.3 MSN Labs Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.6.4 MSN Labs Lesinurad Product Portfolio
- 6.6.5 MSN Labs Recent Developments
- 6.7 Nifty Labs
- 6.7.1 Nifty Labs Company Information
- 6.7.2 Nifty Labs Business Overview
- 6.7.3 Nifty Labs Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.7.4 Nifty Labs Lesinurad Product Portfolio
- 6.7.5 Nifty Labs Recent Developments
- 6.8 Target Mol
- 6.8.1 Target Mol Company Information
- 6.8.2 Target Mol Business Overview
- 6.8.3 Target Mol Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.8.4 Target Mol Lesinurad Product Portfolio
- 6.8.5 Target Mol Recent Developments
- 6.9 UQUIFA
- 6.9.1 UQUIFA Company Information
- 6.9.2 UQUIFA Business Overview
- 6.9.3 UQUIFA Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.9.4 UQUIFA Lesinurad Product Portfolio
- 6.9.5 UQUIFA Recent Developments
- 6.10 Meso Chem
- 6.10.1 Meso Chem Company Information
- 6.10.2 Meso Chem Business Overview
- 6.10.3 Meso Chem Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.10.4 Meso Chem Lesinurad Product Portfolio
- 6.10.5 Meso Chem Recent Developments
- 6.11 Vcare Pharmatech
- 6.11.1 Vcare Pharmatech Company Information
- 6.11.2 Vcare Pharmatech Business Overview
- 6.11.3 Vcare Pharmatech Lesinurad Production, Value and Gross Margin (2021-2026)
- 6.11.4 Vcare Pharmatech Lesinurad Product Portfolio
- 6.11.5 Vcare Pharmatech Recent Developments
7 Global Lesinurad Production by Region
- 7.1 Global Lesinurad Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Lesinurad Production by Region (2021-2032)
- 7.2.1 Global Lesinurad Production by Region (2021-2026)
- 7.2.2 Global Lesinurad Production Forecast by Region (2027-2032)
- 7.3 Global Lesinurad Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Lesinurad Production Value by Region (2021-2032)
- 7.4.1 Global Lesinurad Production Value by Region (2021-2026)
- 7.4.2 Global Lesinurad Production Value by Region (2027-2032)
- 7.5 Global Lesinurad Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Lesinurad Production Value (2021-2032)
- 7.6.2 Europe Lesinurad Production Value (2021-2032)
- 7.6.3 Asia-Pacific Lesinurad Production Value (2021-2032)
- 7.6.4 South America Lesinurad Production Value (2021-2032)
- 7.6.5 Middle East & Africa Lesinurad Production Value (2021-2032)
8 Global Lesinurad Consumption by Region
- 8.1 Global Lesinurad Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Lesinurad Consumption by Region (2021-2032)
- 8.2.1 Global Lesinurad Consumption by Region (2021-2026)
- 8.2.2 Global Lesinurad Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Lesinurad Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Lesinurad Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Lesinurad Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Lesinurad Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Lesinurad Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Lesinurad Value Chain Analysis
- 9.1.1 Lesinurad Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Lesinurad Production Mode & Process
- 9.2 Lesinurad Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lesinurad Distributors
- 9.2.3 Lesinurad Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst